120 related articles for article (PubMed ID: 20394411)
1. A practical and azide-free synthetic approach to oseltamivir from diethyl D-tartrate.
Weng J; Li YB; Wang RB; Li FQ; Liu C; Chan AS; Lu G
J Org Chem; 2010 May; 75(9):3125-8. PubMed ID: 20394411
[TBL] [Abstract][Full Text] [Related]
2. High-yielding synthesis of the anti-influenza neuraminidase inhibitor (-)-oseltamivir by two "one-pot" sequences.
Ishikawa H; Suzuki T; Orita H; Uchimaru T; Hayashi Y
Chemistry; 2010 Nov; 16(42):12616-26. PubMed ID: 20859964
[TBL] [Abstract][Full Text] [Related]
3. An iron carbonyl approach to the influenza neuraminidase inhibitor oseltamivir.
Bromfield KM; Gradén H; Hagberg DP; Olsson T; Kann N
Chem Commun (Camb); 2007 Aug; (30):3183-5. PubMed ID: 17653382
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH
J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083
[No Abstract] [Full Text] [Related]
5. A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1,3-butadiene and acrylic acid.
Yeung YY; Hong S; Corey EJ
J Am Chem Soc; 2006 May; 128(19):6310-1. PubMed ID: 16683783
[TBL] [Abstract][Full Text] [Related]
6. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
Du QS; Wang SQ; Chou KC
Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
[TBL] [Abstract][Full Text] [Related]
7. Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor.
Gong J; Xu W
Curr Med Chem; 2008; 15(30):3145-59. PubMed ID: 19075659
[TBL] [Abstract][Full Text] [Related]
8. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
Magano J
Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
[No Abstract] [Full Text] [Related]
9. Efficient formal synthesis of oseltamivir phosphate (Tamiflu) with inexpensive D-ribose as the starting material.
Osato H; Jones IL; Chen A; Chai CL
Org Lett; 2010 Jan; 12(1):60-3. PubMed ID: 19938847
[TBL] [Abstract][Full Text] [Related]
10. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
Mitrasinovic PM
Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
[TBL] [Abstract][Full Text] [Related]
11. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Evaluation of
Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617
[TBL] [Abstract][Full Text] [Related]
13. [Design, synthesis and activity of a new type of influenza virus N1 neuraminidase inhibitors].
Yang F; Jin L; Huang NY; Chen F; Luo HJ; Chen JF
Yao Xue Xue Bao; 2011 Nov; 46(11):1344-8. PubMed ID: 22260026
[TBL] [Abstract][Full Text] [Related]
14. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
Park JW; Jo WH
Eur J Med Chem; 2010 Feb; 45(2):536-41. PubMed ID: 19914748
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of oseltamivir and tamiphosphor from N-acetyl-D-glucosamine.
Chen CA; Fang JM
Org Biomol Chem; 2013 Nov; 11(44):7687-99. PubMed ID: 24108094
[TBL] [Abstract][Full Text] [Related]
16. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
Stanley M; Martin SR; Birge M; Carbain B; Streicher H
Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
[TBL] [Abstract][Full Text] [Related]
17. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant.
García-Sosa AT; Sild S; Maran U
J Chem Inf Model; 2008 Oct; 48(10):2074-80. PubMed ID: 18847186
[TBL] [Abstract][Full Text] [Related]
18. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S
Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747
[TBL] [Abstract][Full Text] [Related]
19. Symmetry-based design for the chemoenzymatic synthesis of oseltamivir (Tamiflu) from ethyl benzoate.
Sullivan B; Carrera I; Drouin M; Hudlicky T
Angew Chem Int Ed Engl; 2009; 48(23):4229-31. PubMed ID: 19425033
[TBL] [Abstract][Full Text] [Related]
20. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
Wang SQ; Du QS; Chou KC
Biochem Biophys Res Commun; 2007 Mar; 354(3):634-40. PubMed ID: 17266937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
